An Extension Study of Duloxetine in Fibromyalgia (Extension of F1J-JE-HMGZ NCT01552057)

The purpose of the study is to assess the safety and efficacy of duloxetine in participants
with fibromyalgia at long-term use.

Clinical Trial Conditions: Fibromyalgia

Treatments in this Clinical Trial : Duloxetine

Clinical Trial Phase: Phase 3

Eligible Clinical Trial Participant Age : Between 20 years to 74 years

Can Healthy Volunteers Participate: No

Clinical Trial Lead Sponsor: Eli Lilly and Company

Detailed Clinical Trial Description: The purpose of the study is to assess the safety and efficacy of duloxetine in participants
with fibromyalgia at long-term use.

The clinical trial information was obtained from http://clinicaltrials.gov/ct2/show/NCT01621191